Business · 31/10/2006Updated: 10/17/2026 · 1 min read
FDA Submits Information Collection for OMB Review on Xenotransplantation
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, focusing on infectious disease issues in xenotransplantation.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →